What did @_life_with_kaitlyn actually say?
She's two weeks into compound semaglutide, still on a starting dose of 0.25 mg combined with B12, and claims 3.4 pounds lost in week two, with 6.4 pounds total across both weeks. She's also doing low-carb or keto alongside the medication.
The most specific claim she makes is about appetite suppression, describing what researchers call "food noise" reduction: "I don't think about food constantly" and noting she no longer counts down to meals. She also encourages viewers who are "thinking about it" to "jump on board," framing the injection as nearly painless and straightforward. She's transparent that she has a doctor's appointment to discuss dose escalation for weeks five through eight, which is worth noting as a point of responsible disclosure. She is not claiming this is a cure for anything, but the enthusiastic "you won't be sorry" closer is the kind of blanket endorsement that should come with context.
Does the science back this up?
On the weight loss numbers: 3.4 pounds in one week is plausible but sits at the high end of what clinical data predicts at a 0.25 mg starting dose. The food noise reduction claim, however, is well-supported by evidence.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide produced an average of about 14.9% body weight reduction over 68 weeks, but week-to-week results at initiation vary widely depending on baseline diet, water retention, and individual response. A 2022 study by Rubino et al. in JAMA also demonstrated that appetite suppression and reduced food preoccupation are among the earliest and most consistent effects reported by semaglutide users, often appearing before significant weight loss accumulates. The "food noise" mechanism is tied to GLP-1 receptor activity in the hypothalamus and brainstem, per a 2023 review by van Bloemendaal et al. in Diabetes Care. So her description of reduced meal obsession is not anecdote, it reflects documented pharmacology.
What did they get wrong (or right)?
She got the appetite suppression description right. Where things get murkier is the B12 combination and the dose unit framing.
She references "75 units" as her prescription measure, which is a volume-based description from a compounding pharmacy, not a standardized clinical dose. This matters because compounded semaglutide formulations are not FDA-approved, and their concentration, purity, and dosing equivalency to brand-name Wegovy or Ozempic cannot be assumed to be identical. The FDA has issued repeated warnings about compounded semaglutide quality concerns, including in a 2024 alert flagging dosing errors with compounded versions. The B12 addition is common in compounding, often marketed as an energy and tolerability booster, but there is no peer-reviewed evidence that B12 meaningfully enhances semaglutide's weight loss effect. She does not claim it does, to her credit, but the hashtag pairing of "b12" and "weightloss" implies a synergy that the data does not support. Her early weight loss also likely includes water weight from the concurrent low-carb diet, not purely a medication effect.
What should you actually know?
If you're considering compound semaglutide, the regulatory picture matters more than a week-two weigh-in, however relatable it is.
The FDA placed compounded semaglutide on its shortage list, which allowed compounding pharmacies to produce it legally, but that shortage status was officially ended for tirzepatide in 2024 and semaglutide policy has continued to shift. That means the legal landscape for compounded versions is actively changing. The STEP trials consistently show real, clinically meaningful weight loss with semaglutide, but the studies used FDA-approved formulations at verified doses. Compounded versions may work similarly for many people, but "may work similarly" is not the same as verified equivalency. Early weeks also tend to show faster scale movement due to glycogen depletion and water loss, particularly on a low-carb diet. Expecting 3-plus pounds every week is not realistic over the longer term. Anyone starting this medication should have a prescribing clinician monitoring for side effects including nausea, pancreatitis risk, and thyroid concerns, and dose escalation decisions should be made with a provider, not based on a TikTok weigh-in timeline.